Nemaura Med Inc (NQ: NMRD )

4.140 USD UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2022 Add to My Watchlist

Price and Volume

Volume	0
Open	4.140
Bid (Size)	3.850 (10)
Ask (Size)	4.550 (97)
Prev. Close	4.140
Today's Range	4.140 - 4.140
52wk Range	3.570 - 17.40
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

January 24, 2022

Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee

January 20, 2022

Performance

YTD	-11.16%	-11.16%
1 Month	-7.38%	-7.38%
3 Month	-30.30%	-30.30%
6 Month	-47.06%	-47.06%
1 Year	-20.69%	-20.69%

More News

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Launches Miboko – a New Metabolic Health Program

January 13, 2022

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names Industry Veteran as COO

January 10, 2022

Nemaura Medical Commences Rollout of Miboko Application

January 25, 2022

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference

January 07, 2022

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks True Milestone in Development, Growth

January 04, 2022

Nemaura Medical Firmly Positioned in Growing Diabetes Tech Market

January 21, 2022

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Solutions to Empower People to Take Charge of Their Health, Well-Being

December 29, 2021

Nemaura Medical Launches Miboko – A New Metabolic Health Program

January 14, 2022

Nemaura Medical Inc. (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee

December 22, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.